Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease

Craig Broberg, Luke Burchill

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Pioneers in congenital heart surgery observed that exercise capacity did not return to normal levels despite successful surgical repair, leading some to cite a "myocardial factor" playing a role. They conjectured that residual alterations in myocardial function would be significant for patients' long-term outlook. In fulfillment of their early observations, today's adult congenital heart disease (ACHD) population shows well-recognized features of heart failure, even among patients without clear residual anatomic or hemodynamic abnormalities, demonstrating the vital role of the myocardium in their morbidity and mortality. Whereas the 'myocardial factor' was an elusive concept in the early history of congenital heart care, we now have imaging techniques to detect and quantify one such factor - myocardial fibrosis. Understanding the importance of myocardial fibrosis as a final common pathway in a variety of congenital lesions provides a framework for both the study and treatment of clinical heart failure in this context. While typical heart failure pharmacology should reduce or attenuate fibrogenesis, efforts to show meaningful improvements with standard pharmacotherapy in ACHD repeatedly fall short. This paper considers the importance of myocardial fibrosis and function, the current body of evidence for myocardial fibrosis in ACHD, and its implications for research and treatment.

    Original languageEnglish (US)
    Pages (from-to)204-210
    Number of pages7
    JournalInternational Journal of Cardiology
    Volume189
    Issue number1
    DOIs
    StatePublished - Jun 15 2015

    Fingerprint

    Heart Diseases
    Fibrosis
    Heart Failure
    Thoracic Surgery
    Myocardium
    Hemodynamics
    History
    Pharmacology
    Exercise
    Morbidity
    Drug Therapy
    Mortality
    Therapeutics
    Research
    Population

    Keywords

    • Cardiac magnetic resonance
    • Congenital
    • Heart defects
    • Heart failure
    • Myocardial fibrosis

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Myocardial factor revisited : The importance of myocardial fibrosis in adults with congenital heart disease. / Broberg, Craig; Burchill, Luke.

    In: International Journal of Cardiology, Vol. 189, No. 1, 15.06.2015, p. 204-210.

    Research output: Contribution to journalArticle

    @article{eca3e6090ec845ce94d59a192b71e509,
    title = "Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease",
    abstract = "Pioneers in congenital heart surgery observed that exercise capacity did not return to normal levels despite successful surgical repair, leading some to cite a {"}myocardial factor{"} playing a role. They conjectured that residual alterations in myocardial function would be significant for patients' long-term outlook. In fulfillment of their early observations, today's adult congenital heart disease (ACHD) population shows well-recognized features of heart failure, even among patients without clear residual anatomic or hemodynamic abnormalities, demonstrating the vital role of the myocardium in their morbidity and mortality. Whereas the 'myocardial factor' was an elusive concept in the early history of congenital heart care, we now have imaging techniques to detect and quantify one such factor - myocardial fibrosis. Understanding the importance of myocardial fibrosis as a final common pathway in a variety of congenital lesions provides a framework for both the study and treatment of clinical heart failure in this context. While typical heart failure pharmacology should reduce or attenuate fibrogenesis, efforts to show meaningful improvements with standard pharmacotherapy in ACHD repeatedly fall short. This paper considers the importance of myocardial fibrosis and function, the current body of evidence for myocardial fibrosis in ACHD, and its implications for research and treatment.",
    keywords = "Cardiac magnetic resonance, Congenital, Heart defects, Heart failure, Myocardial fibrosis",
    author = "Craig Broberg and Luke Burchill",
    year = "2015",
    month = "6",
    day = "15",
    doi = "10.1016/j.ijcard.2015.04.064",
    language = "English (US)",
    volume = "189",
    pages = "204--210",
    journal = "International Journal of Cardiology",
    issn = "0167-5273",
    publisher = "Elsevier Ireland Ltd",
    number = "1",

    }

    TY - JOUR

    T1 - Myocardial factor revisited

    T2 - The importance of myocardial fibrosis in adults with congenital heart disease

    AU - Broberg, Craig

    AU - Burchill, Luke

    PY - 2015/6/15

    Y1 - 2015/6/15

    N2 - Pioneers in congenital heart surgery observed that exercise capacity did not return to normal levels despite successful surgical repair, leading some to cite a "myocardial factor" playing a role. They conjectured that residual alterations in myocardial function would be significant for patients' long-term outlook. In fulfillment of their early observations, today's adult congenital heart disease (ACHD) population shows well-recognized features of heart failure, even among patients without clear residual anatomic or hemodynamic abnormalities, demonstrating the vital role of the myocardium in their morbidity and mortality. Whereas the 'myocardial factor' was an elusive concept in the early history of congenital heart care, we now have imaging techniques to detect and quantify one such factor - myocardial fibrosis. Understanding the importance of myocardial fibrosis as a final common pathway in a variety of congenital lesions provides a framework for both the study and treatment of clinical heart failure in this context. While typical heart failure pharmacology should reduce or attenuate fibrogenesis, efforts to show meaningful improvements with standard pharmacotherapy in ACHD repeatedly fall short. This paper considers the importance of myocardial fibrosis and function, the current body of evidence for myocardial fibrosis in ACHD, and its implications for research and treatment.

    AB - Pioneers in congenital heart surgery observed that exercise capacity did not return to normal levels despite successful surgical repair, leading some to cite a "myocardial factor" playing a role. They conjectured that residual alterations in myocardial function would be significant for patients' long-term outlook. In fulfillment of their early observations, today's adult congenital heart disease (ACHD) population shows well-recognized features of heart failure, even among patients without clear residual anatomic or hemodynamic abnormalities, demonstrating the vital role of the myocardium in their morbidity and mortality. Whereas the 'myocardial factor' was an elusive concept in the early history of congenital heart care, we now have imaging techniques to detect and quantify one such factor - myocardial fibrosis. Understanding the importance of myocardial fibrosis as a final common pathway in a variety of congenital lesions provides a framework for both the study and treatment of clinical heart failure in this context. While typical heart failure pharmacology should reduce or attenuate fibrogenesis, efforts to show meaningful improvements with standard pharmacotherapy in ACHD repeatedly fall short. This paper considers the importance of myocardial fibrosis and function, the current body of evidence for myocardial fibrosis in ACHD, and its implications for research and treatment.

    KW - Cardiac magnetic resonance

    KW - Congenital

    KW - Heart defects

    KW - Heart failure

    KW - Myocardial fibrosis

    UR - http://www.scopus.com/inward/record.url?scp=84929155828&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84929155828&partnerID=8YFLogxK

    U2 - 10.1016/j.ijcard.2015.04.064

    DO - 10.1016/j.ijcard.2015.04.064

    M3 - Article

    C2 - 25897907

    AN - SCOPUS:84929155828

    VL - 189

    SP - 204

    EP - 210

    JO - International Journal of Cardiology

    JF - International Journal of Cardiology

    SN - 0167-5273

    IS - 1

    ER -